International Journal of Clinical Oncology, volume 26, issue 1, pages 18-25
Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy
1
Department of Urology, Kochi Medical School, Nankoku, Japan
|
Publication type: Journal Article
Publication date: 2020-05-26
Quartile SCImago
Q1
Quartile WOS
Q3
Impact factor: 3.3
ISSN: 13419625, 14377772
Oncology
General Medicine
Surgery
Hematology
Abstract
Photodynamic technology using light-sensitive and fluorescent substances has an important role in an accurate diagnosis for a variety of malignancies, including bladder cancer and prostate cancer. Light-sensitive and fluorescent substances accumulate specifically in tumor cells compared to normal tissue, and by light irradiation and excitation at each specific wavelength, tumor lesion, blood flow, lymph node and so on show fluorescence. 5-Aminolevulinic acid (ALA) is converted to protoporphyrin IX (PpIX) into mitochondria. PpIX is excited by blue light, red fluorescence is emitted in the mitochondria. This phenomenon is the mechanism of ALA-mediated photodynamic diagnosis (ALA-PDD). ALA-PDD has made it possible to visualize smaller lesions and flat lesions that were previously difficult to visualize by endoscope using a white-light source. So accurate diagnosis and complete resection become possible during operation. The accumulation of PpIX in the mitochondria also induces direct mitochondrial damage and subsequent cell death by red and green light. This biological reaction is the ALA-mediate photodynamic therapy (ALA-PDT). ALA-PDT has been developed as a modality for minimum invasive cancer treatment that utilizes low-energy light and photosensitizer. Vascular-activated photosensitizer induces rapid tumor ablation by PDT involving direct tumor cell killing as well as damage to the exposed microvasculature. We summarize the clinical outcomes of PDD and PDT for urothelial carcinoma and prostate cancer.
Citations by journals
1
2
3
|
|
Molecules
|
Molecules
3 publications, 12%
|
Cancers
|
Cancers
2 publications, 8%
|
Pharmaceutics
|
Pharmaceutics
2 publications, 8%
|
Frontiers in Chemistry
|
Frontiers in Chemistry
2 publications, 8%
|
Photochemistry and Photobiology
|
Photochemistry and Photobiology
2 publications, 8%
|
Journal of Medicinal Chemistry
|
Journal of Medicinal Chemistry
1 publication, 4%
|
Current Opinion in Urology
|
Current Opinion in Urology
1 publication, 4%
|
Pharmaceuticals
|
Pharmaceuticals
1 publication, 4%
|
Applied Sciences (Switzerland)
|
Applied Sciences (Switzerland)
1 publication, 4%
|
Diagnostics
|
Diagnostics
1 publication, 4%
|
Frontiers in Oncology
|
Frontiers in Oncology
1 publication, 4%
|
Cell Death and Disease
|
Cell Death and Disease
1 publication, 4%
|
International Journal of Pharmaceutics
|
International Journal of Pharmaceutics
1 publication, 4%
|
ACS Omega
|
ACS Omega
1 publication, 4%
|
Artificial Cells, Nanomedicine and Biotechnology
|
Artificial Cells, Nanomedicine and Biotechnology
1 publication, 4%
|
Translational Andrology and Urology
|
Translational Andrology and Urology
1 publication, 4%
|
Progress in Materials Science
|
Progress in Materials Science
1 publication, 4%
|
Science China Life Sciences
|
Science China Life Sciences
1 publication, 4%
|
Photodiagnosis and Photodynamic Therapy
|
Photodiagnosis and Photodynamic Therapy
1 publication, 4%
|
1
2
3
|
Citations by publishers
2
4
6
8
10
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
10 publications, 40%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
3 publications, 12%
|
Elsevier
|
Elsevier
3 publications, 12%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
2 publications, 8%
|
Springer Nature
|
Springer Nature
2 publications, 8%
|
Wiley
|
Wiley
2 publications, 8%
|
Wolters Kluwer Health
|
Wolters Kluwer Health
1 publication, 4%
|
Taylor & Francis
|
Taylor & Francis
1 publication, 4%
|
AME Publishing Company
|
AME Publishing Company
1 publication, 4%
|
2
4
6
8
10
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2020,2021,2022,2023,2024],"ids":[0,0,0,0,0],"codes":[0,0,0,0,0],"imageUrls":["","","","",""],"datasets":[{"label":"Citations number","data":[3,9,6,5,2],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["12","36","24","20","8"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Molecules","Cancers","Pharmaceutics","Frontiers in Chemistry","Photochemistry and Photobiology","Journal of Medicinal Chemistry","Current Opinion in Urology","Pharmaceuticals","Applied Sciences (Switzerland)","Diagnostics","Frontiers in Oncology","Cell Death and Disease","International Journal of Pharmaceutics","ACS Omega","Artificial Cells, Nanomedicine and Biotechnology","Translational Andrology and Urology","Progress in Materials Science","Science China Life Sciences","Photodiagnosis and Photodynamic Therapy"],"ids":[1770,22471,4502,6407,2408,3673,14216,1203,16650,18499,10990,25236,3305,18901,8626,23759,21250,8991,7488],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/PYBAYQjpFdxPQPRGY3kU5Xzbu0W7K7umVNk0TY9i_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp"],"datasets":[{"label":"","data":[3,2,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[12,8,8,8,8,4,4,4,4,4,4,4,4,4,4,4,4,4,4],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Multidisciplinary Digital Publishing Institute (MDPI)","Frontiers Media S.A.","Elsevier","American Chemical Society (ACS)","Springer Nature","Wiley","Wolters Kluwer Health","Taylor & Francis","AME Publishing Company"],"ids":[202,208,17,40,8,11,32,18,1566],"codes":[0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/PYBAYQjpFdxPQPRGY3kU5Xzbu0W7K7umVNk0TY9i_medium.webp"],"datasets":[{"label":"","data":[10,3,3,2,2,2,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[40,12,12,8,8,8,4,4,4],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Fukuhara H. et al. Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy // International Journal of Clinical Oncology. 2020. Vol. 26. No. 1. pp. 18-25.
GOST all authors (up to 50)
Copy
Fukuhara H., Yamamoto S., Karashima T., Inoue K. Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy // International Journal of Clinical Oncology. 2020. Vol. 26. No. 1. pp. 18-25.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1007/s10147-020-01704-y
UR - https://doi.org/10.1007%2Fs10147-020-01704-y
TI - Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy
T2 - International Journal of Clinical Oncology
AU - Fukuhara, Hideo
AU - Yamamoto, Shinkuro
AU - Karashima, Takashi
AU - Inoue, Keiji
PY - 2020
DA - 2020/05/26 00:00:00
PB - Springer Nature
SP - 18-25
IS - 1
VL - 26
SN - 1341-9625
SN - 1437-7772
ER -
Cite this
BibTex
Copy
@article{2020_Fukuhara
author = {Hideo Fukuhara and Shinkuro Yamamoto and Takashi Karashima and Keiji Inoue},
title = {Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy},
journal = {International Journal of Clinical Oncology},
year = {2020},
volume = {26},
publisher = {Springer Nature},
month = {may},
url = {https://doi.org/10.1007%2Fs10147-020-01704-y},
number = {1},
pages = {18--25},
doi = {10.1007/s10147-020-01704-y}
}
Cite this
MLA
Copy
Fukuhara, Hideo, et al. “Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy.” International Journal of Clinical Oncology, vol. 26, no. 1, May. 2020, pp. 18-25. https://doi.org/10.1007%2Fs10147-020-01704-y.